Effect of the LDL receptor mutation type on incident major adverse cardiovascular events in familial hypercholesterolaemia.

Carriers of a null mutation have an independent ∼2-fold increased risk of incident MACE compared with patients carrying a defective mutation. This study highlights the importance of genetic screening in FH in order to improve patient care.